128 related articles for article (PubMed ID: 38416410)
1. Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II.
Hanna GJ; Grover P; Elliott A; McGrath J; Xiu J; Sukari A; Johnson JM; Wise-Draper T
Clin Cancer Res; 2024 May; 30(10):2225-2232. PubMed ID: 38416410
[TBL] [Abstract][Full Text] [Related]
2. Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.
Chae YK; Chung SY; Davis AA; Carneiro BA; Chandra S; Kaplan J; Kalyan A; Giles FJ
Oncotarget; 2015 Nov; 6(35):37117-34. PubMed ID: 26359351
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets.
Ferrarotto R; Mitani Y; McGrail DJ; Li K; Karpinets TV; Bell D; Frank SJ; Song X; Kupferman ME; Liu B; Lee JJ; Glisson BS; Zhang J; Aster JC; Lin SY; Futreal PA; Heymach JV; El-Naggar AK
Clin Cancer Res; 2021 Feb; 27(3):852-864. PubMed ID: 33172898
[TBL] [Abstract][Full Text] [Related]
4. Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments.
de Sousa LG; Jovanovic K; Ferrarotto R
Curr Treat Options Oncol; 2022 Aug; 23(8):1135-1150. PubMed ID: 35854180
[TBL] [Abstract][Full Text] [Related]
5. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma.
Thierauf J; Ramamurthy N; Jo VY; Robinson H; Frazier RP; Gonzalez J; Pacula M; Dominguez Meneses E; Nose V; Nardi V; Dias-Santagata D; Le LP; Lin DT; Faquin WC; Wirth LJ; Hess J; Iafrate AJ; Lennerz JK
Oncologist; 2019 Oct; 24(10):1356-1367. PubMed ID: 30926674
[TBL] [Abstract][Full Text] [Related]
6. The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication.
Dou S; Li R; He N; Zhang M; Jiang W; Ye L; Yang Y; Zhao G; Yang Y; Li J; Chen D; Zhu G
Front Immunol; 2021; 12():618367. PubMed ID: 34552580
[TBL] [Abstract][Full Text] [Related]
7. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma.
Tadi S; Cheung VK; Lee CS; Nguyen K; Luk PP; Low TH; Palme C; Clark J; Gupta R
Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331
[TBL] [Abstract][Full Text] [Related]
8. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
[TBL] [Abstract][Full Text] [Related]
9. Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
Feeney L; Hapuarachi B; Adderley H; Rack S; Morgan D; Walker R; Rauch R; Herz E; Kaye J; Harrington K; Metcalf R
Oral Oncol; 2022 Oct; 133():106028. PubMed ID: 35952580
[TBL] [Abstract][Full Text] [Related]
10. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
Sousa LG; McGrail DJ; Lazar Neto F; Li K; Marques-Piubelli ML; Ferri-Borgogno S; Dai H; Mitani Y; Spardy Burr N; Cooper ZA; Kinneer K; Cortez MA; Lin SY; Bell D; El Naggar A; Burks J; Ferrarotto R
Clin Cancer Res; 2023 Aug; 29(16):3162-3171. PubMed ID: 37256648
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
[TBL] [Abstract][Full Text] [Related]
13. Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
Humtsoe JO; Kim HS; Leonard B; Ling S; Keam B; Marchionni L; Afsari B; Considine M; Favorov AV; Fertig EJ; Kang H; Ha PK
Cancer Res; 2021 Feb; 81(4):1001-1013. PubMed ID: 33408119
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.
Ho AL; Dunn L; Sherman EJ; Fury MG; Baxi SS; Chandramohan R; Dogan S; Morris LG; Cullen GD; Haque S; Sima CS; Ni A; Antonescu CR; Katabi N; Pfister DG
Ann Oncol; 2016 Oct; 27(10):1902-8. PubMed ID: 27566443
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapies for salivary gland adenoid cystic carcinoma.
Sahara S; Herzog AE; Nör JE
Am J Cancer Res; 2021; 11(9):4092-4110. PubMed ID: 34659878
[TBL] [Abstract][Full Text] [Related]
17. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
Xie M; Wei S; Wu X; Li X; You Y; He C
Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
[TBL] [Abstract][Full Text] [Related]
18. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
Rettig EM; Tan M; Ling S; Yonescu R; Bishop JA; Fakhry C; Ha PK
Laryngoscope; 2015 Sep; 125(9):E292-9. PubMed ID: 25963073
[TBL] [Abstract][Full Text] [Related]
19.
Hou H; Jia D; Yan W; Zhang X; Wang C; Li Y; Chen H; Huang W; Li Z; Zhang X
Transl Cancer Res; 2020 Aug; 9(8):4703-4714. PubMed ID: 35117834
[TBL] [Abstract][Full Text] [Related]
20. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.
Ho AS; Ochoa A; Jayakumaran G; Zehir A; Valero Mayor C; Tepe J; Makarov V; Dalin MG; He J; Bailey M; Montesion M; Ross JS; Miller VA; Chan L; Ganly I; Dogan S; Katabi N; Tsipouras P; Ha P; Agrawal N; Solit DB; Futreal PA; El Naggar AK; Reis-Filho JS; Weigelt B; Ho AL; Schultz N; Chan TA; Morris LG
J Clin Invest; 2019 Oct; 129(10):4276-4289. PubMed ID: 31483290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
